NTRA Quote, Financials, Valuation and Earnings

EXACT Sciences Corp. has a net margin of -14.78% compared to Natera, Inc.'s net margin of -2.3%. Natera, Inc.'s return on equity of -26.6% beat EXACT Sciences Corp.'s return on equity of -38%.

Natera, Inc. has a consensus price target of $246.26, signalling upside risk potential of 4.55%. On the other hand EXACT Sciences Corp. has an analysts' consensus of $104.56 which suggests that it could grow by 2.98%. Given that Natera, Inc. has higher upside potential than EXACT Sciences Corp., analysts believe Natera, Inc. is more attractive than EXACT Sciences Corp..

Natera, Inc. has a beta of 1.628, which suggesting that the stock is 62.801% more volatile than S&P 500. In comparison EXACT Sciences Corp. has a beta of 1.417, suggesting its more volatile than the S&P 500 by 41.664%.

Natera, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. EXACT Sciences Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera, Inc. pays -- of its earnings as a dividend. EXACT Sciences Corp. pays out -- of its earnings as a dividend.

Natera, Inc. quarterly revenues are $592.2M, which are smaller than EXACT Sciences Corp. quarterly revenues of $850.7M. Natera, Inc.'s net income of -$87.5M is lower than EXACT Sciences Corp.'s net income of -$19.6M. Notably, Natera, Inc.'s price-to-earnings ratio is -- while EXACT Sciences Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera, Inc. is 15.01x versus 6.18x for EXACT Sciences Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Guardant Health, Inc. has a net margin of -14.78% compared to Natera, Inc.'s net margin of -34.97%. Natera, Inc.'s return on equity of -26.6% beat Guardant Health, Inc.'s return on equity of -8518.58%.

Natera, Inc. has a consensus price target of $246.26, signalling upside risk potential of 4.55%. On the other hand Guardant Health, Inc. has an analysts' consensus of $114.05 which suggests that it could grow by 11.4%. Given that Guardant Health, Inc. has higher upside potential than Natera, Inc., analysts believe Guardant Health, Inc. is more attractive than Natera, Inc..

Natera, Inc. has a beta of 1.628, which suggesting that the stock is 62.801% more volatile than S&P 500. In comparison Guardant Health, Inc. has a beta of 1.579, suggesting its more volatile than the S&P 500 by 57.876%.

Natera, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Guardant Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera, Inc. pays -- of its earnings as a dividend. Guardant Health, Inc. pays out -- of its earnings as a dividend.

Natera, Inc. quarterly revenues are $592.2M, which are larger than Guardant Health, Inc. quarterly revenues of $265.2M. Natera, Inc.'s net income of -$87.5M is higher than Guardant Health, Inc.'s net income of -$92.7M. Notably, Natera, Inc.'s price-to-earnings ratio is -- while Guardant Health, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera, Inc. is 15.01x versus 14.08x for Guardant Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Illumina, Inc. has a net margin of -14.78% compared to Natera, Inc.'s net margin of 13.85%. Natera, Inc.'s return on equity of -26.6% beat Illumina, Inc.'s return on equity of 30.55%.

Natera, Inc. has a consensus price target of $246.26, signalling upside risk potential of 4.55%. On the other hand Illumina, Inc. has an analysts' consensus of $125.28 which suggests that it could fall by -7.42%. Given that Natera, Inc. has higher upside potential than Illumina, Inc., analysts believe Natera, Inc. is more attractive than Illumina, Inc..

Natera, Inc. has a beta of 1.628, which suggesting that the stock is 62.801% more volatile than S&P 500. In comparison Illumina, Inc. has a beta of 1.438, suggesting its more volatile than the S&P 500 by 43.845%.

Natera, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Illumina, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera, Inc. pays -- of its earnings as a dividend. Illumina, Inc. pays out -- of its earnings as a dividend.

Natera, Inc. quarterly revenues are $592.2M, which are smaller than Illumina, Inc. quarterly revenues of $1.1B. Natera, Inc.'s net income of -$87.5M is lower than Illumina, Inc.'s net income of $150M. Notably, Natera, Inc.'s price-to-earnings ratio is -- while Illumina, Inc.'s PE ratio is 30.32x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera, Inc. is 15.01x versus 4.97x for Illumina, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Mettler-Toledo International, Inc. has a net margin of -14.78% compared to Natera, Inc.'s net margin of 21.12%. Natera, Inc.'s return on equity of -26.6% beat Mettler-Toledo International, Inc.'s return on equity of --.

Natera, Inc. has a consensus price target of $246.26, signalling upside risk potential of 4.55%. On the other hand Mettler-Toledo International, Inc. has an analysts' consensus of $1,495.69 which suggests that it could grow by 5.54%. Given that Mettler-Toledo International, Inc. has higher upside potential than Natera, Inc., analysts believe Mettler-Toledo International, Inc. is more attractive than Natera, Inc..

Natera, Inc. has a beta of 1.628, which suggesting that the stock is 62.801% more volatile than S&P 500. In comparison Mettler-Toledo International, Inc. has a beta of 1.397, suggesting its more volatile than the S&P 500 by 39.716%.

Natera, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Mettler-Toledo International, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera, Inc. pays -- of its earnings as a dividend. Mettler-Toledo International, Inc. pays out -- of its earnings as a dividend.

Natera, Inc. quarterly revenues are $592.2M, which are smaller than Mettler-Toledo International, Inc. quarterly revenues of $1B. Natera, Inc.'s net income of -$87.5M is lower than Mettler-Toledo International, Inc.'s net income of $217.5M. Notably, Natera, Inc.'s price-to-earnings ratio is -- while Mettler-Toledo International, Inc.'s PE ratio is 35.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera, Inc. is 15.01x versus 7.49x for Mettler-Toledo International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.